Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Standardized Withaferin A as GvHD Prophylaxis in Hematopoietic Stem Cell Transplant
NCT07724873Phase 2Recruiting
- Sponsor
- Tata Memorial Centre
- Start
- Jan 2025
- Primary completion
- Dec 2029
- Countries
- 1
01
Overview
A Phase 2 trial of withaferin a in graft-versus-host disease (GVHD), sponsored by Tata Memorial Centre. Started Jan 2025; status: recruiting.
02
Drugs
withaferin a
03
Conditions
graft-versus-host disease (GVHD)
Beyond the preview
Go deeper on NCT07724873.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07724873.